Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.
Hevea
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Mycoplasmataceae
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis.
See All 41 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis.
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
View in:
PubMed
subject areas
Adult
Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Chronic Disease
Double-Blind Method
Female
Health Status Indicators
Humans
Immunoglobulin E
Male
Middle Aged
Omalizumab
Quality of Life
Rhinitis
Sinusitis
Treatment Outcome
authors with profiles
Robert M. Naclerio
Fuad Baroody
Jayant Pinto